Magazine

The leading source for ASAM society and addiction medicine news.

ASAM Applauds Appointment of Kimberly Johnson, PhD to Serve as Director of Center for Substance Abuse Treatment (CSAT) within SAMHSA

by | Feb 23, 2016

FOR IMMEDIATE RELEASE

2/8/2016

CHEVY CHASE, MD –  The American Society of Addiction Medicine (ASAM) applauds last weeks announcement that Kimberly Johnson, PhD has been appointed to serve as the next Director of the Center for Substance Abuse Treatment (CSAT) within the Substance Abuse and Mental Health Services Administration (SAMHSA). 

“ASAM has worked with Dr. Johnson and the national office that coordinates the Addiction Technology Transfer Center’s (ATTC) for a number of years,” said ASAM President Dr. Jeffrey Goldsmith. “Now as Director of CSAT, we look forward to her leadership and to the expansion of innovative and effective substance use disorder treatment services, programs and practices.”

Under Dr. Johnson's leadership, the national office of the Addiction Technology Transfer Centers (ATTC) is sponsoring a symposium at ASAM’s 47th Annual Conference – Innovations in Addiction Medicine and Science this April 14-17 in Baltimore, MD. The ASAM 47th Annual Conference is the largest gathering of addiction physicians, psychiatrists, clinicians, researchers and academicians who treat and help patients with substance use disorders.

ASAM looks forward to further partnering with Dr. Johnson and SAMSHA in her new role.

For more information about ASAM or The ASAM 47th Annual Conference – Innovations in Addiction Medicine and Science visit www.ASAM.org

# # #

Contact: Bob Davis, BDavis@ASAM.org, 301.547.4112


Features

PCSS Graphic

Ask the PCSS Expert: Counseling Requirements in Addiction Treatment?

A physician wrote the PCSS mentor network seeking advice on what type of counseling (group/individual/ AA, NA/ therapist) are typically required as part of addiction treatment.

neurons

Brain Stimulation as a Potential Treatment for Addiction

Brain stimulation has been in use for decades as a potential treatment for psychiatric disorders. However, its use in addiction is relatively new.

Unite ImageJoin Rally and Advocate for Addiction Solutions

Help tell our nation’s leaders that we support public health solutions to addiction.

image of the ASAM sealASAM Speaks on FDA Boxed Warnings

ASAM testified on the best approaches to communicating information about the fetal effects in product labeling for methadone and buprenorphine

Photo of Alex Krawczyk-KeefeThe Importance of Donating: One Family’s Story

A donation to honor a son and help those facing the devastating disease of addiction.

Education & Training

ASAM Applauds Appointment of Kimberly Johnson, PhD to Serve as Director of Center for Substance Abuse Treatment (CSAT) within SAMHSA

by | Feb 23, 2016

FOR IMMEDIATE RELEASE

2/8/2016

CHEVY CHASE, MD –  The American Society of Addiction Medicine (ASAM) applauds last weeks announcement that Kimberly Johnson, PhD has been appointed to serve as the next Director of the Center for Substance Abuse Treatment (CSAT) within the Substance Abuse and Mental Health Services Administration (SAMHSA). 

“ASAM has worked with Dr. Johnson and the national office that coordinates the Addiction Technology Transfer Center’s (ATTC) for a number of years,” said ASAM President Dr. Jeffrey Goldsmith. “Now as Director of CSAT, we look forward to her leadership and to the expansion of innovative and effective substance use disorder treatment services, programs and practices.”

Under Dr. Johnson's leadership, the national office of the Addiction Technology Transfer Centers (ATTC) is sponsoring a symposium at ASAM’s 47th Annual Conference – Innovations in Addiction Medicine and Science this April 14-17 in Baltimore, MD. The ASAM 47th Annual Conference is the largest gathering of addiction physicians, psychiatrists, clinicians, researchers and academicians who treat and help patients with substance use disorders.

ASAM looks forward to further partnering with Dr. Johnson and SAMSHA in her new role.

For more information about ASAM or The ASAM 47th Annual Conference – Innovations in Addiction Medicine and Science visit www.ASAM.org

# # #

Contact: Bob Davis, BDavis@ASAM.org, 301.547.4112


Government Affairs

ASAM Applauds Appointment of Kimberly Johnson, PhD to Serve as Director of Center for Substance Abuse Treatment (CSAT) within SAMHSA

by | Feb 23, 2016

FOR IMMEDIATE RELEASE

2/8/2016

CHEVY CHASE, MD –  The American Society of Addiction Medicine (ASAM) applauds last weeks announcement that Kimberly Johnson, PhD has been appointed to serve as the next Director of the Center for Substance Abuse Treatment (CSAT) within the Substance Abuse and Mental Health Services Administration (SAMHSA). 

“ASAM has worked with Dr. Johnson and the national office that coordinates the Addiction Technology Transfer Center’s (ATTC) for a number of years,” said ASAM President Dr. Jeffrey Goldsmith. “Now as Director of CSAT, we look forward to her leadership and to the expansion of innovative and effective substance use disorder treatment services, programs and practices.”

Under Dr. Johnson's leadership, the national office of the Addiction Technology Transfer Centers (ATTC) is sponsoring a symposium at ASAM’s 47th Annual Conference – Innovations in Addiction Medicine and Science this April 14-17 in Baltimore, MD. The ASAM 47th Annual Conference is the largest gathering of addiction physicians, psychiatrists, clinicians, researchers and academicians who treat and help patients with substance use disorders.

ASAM looks forward to further partnering with Dr. Johnson and SAMSHA in her new role.

For more information about ASAM or The ASAM 47th Annual Conference – Innovations in Addiction Medicine and Science visit www.ASAM.org

# # #

Contact: Bob Davis, BDavis@ASAM.org, 301.547.4112


Your ASAM

ASAM Applauds Appointment of Kimberly Johnson, PhD to Serve as Director of Center for Substance Abuse Treatment (CSAT) within SAMHSA

by | Feb 23, 2016

FOR IMMEDIATE RELEASE

2/8/2016

CHEVY CHASE, MD –  The American Society of Addiction Medicine (ASAM) applauds last weeks announcement that Kimberly Johnson, PhD has been appointed to serve as the next Director of the Center for Substance Abuse Treatment (CSAT) within the Substance Abuse and Mental Health Services Administration (SAMHSA). 

“ASAM has worked with Dr. Johnson and the national office that coordinates the Addiction Technology Transfer Center’s (ATTC) for a number of years,” said ASAM President Dr. Jeffrey Goldsmith. “Now as Director of CSAT, we look forward to her leadership and to the expansion of innovative and effective substance use disorder treatment services, programs and practices.”

Under Dr. Johnson's leadership, the national office of the Addiction Technology Transfer Centers (ATTC) is sponsoring a symposium at ASAM’s 47th Annual Conference – Innovations in Addiction Medicine and Science this April 14-17 in Baltimore, MD. The ASAM 47th Annual Conference is the largest gathering of addiction physicians, psychiatrists, clinicians, researchers and academicians who treat and help patients with substance use disorders.

ASAM looks forward to further partnering with Dr. Johnson and SAMSHA in her new role.

For more information about ASAM or The ASAM 47th Annual Conference – Innovations in Addiction Medicine and Science visit www.ASAM.org

# # #

Contact: Bob Davis, BDavis@ASAM.org, 301.547.4112


OP-ED

ASAM Applauds Appointment of Kimberly Johnson, PhD to Serve as Director of Center for Substance Abuse Treatment (CSAT) within SAMHSA

by | Feb 23, 2016

FOR IMMEDIATE RELEASE

2/8/2016

CHEVY CHASE, MD –  The American Society of Addiction Medicine (ASAM) applauds last weeks announcement that Kimberly Johnson, PhD has been appointed to serve as the next Director of the Center for Substance Abuse Treatment (CSAT) within the Substance Abuse and Mental Health Services Administration (SAMHSA). 

“ASAM has worked with Dr. Johnson and the national office that coordinates the Addiction Technology Transfer Center’s (ATTC) for a number of years,” said ASAM President Dr. Jeffrey Goldsmith. “Now as Director of CSAT, we look forward to her leadership and to the expansion of innovative and effective substance use disorder treatment services, programs and practices.”

Under Dr. Johnson's leadership, the national office of the Addiction Technology Transfer Centers (ATTC) is sponsoring a symposium at ASAM’s 47th Annual Conference – Innovations in Addiction Medicine and Science this April 14-17 in Baltimore, MD. The ASAM 47th Annual Conference is the largest gathering of addiction physicians, psychiatrists, clinicians, researchers and academicians who treat and help patients with substance use disorders.

ASAM looks forward to further partnering with Dr. Johnson and SAMSHA in her new role.

For more information about ASAM or The ASAM 47th Annual Conference – Innovations in Addiction Medicine and Science visit www.ASAM.org

# # #

Contact: Bob Davis, BDavis@ASAM.org, 301.547.4112